RxSight, Inc. Form 8-K Filing
2025-12-19SEC Filing 8-K (0001193125-25-326889)
On December 18, 2025, RxSight, Inc. announced changes to its executive leadership. Eric Weinberg transitioned from Chief Commercial Officer to Chief Business Development Officer. Concurrently, Scott Gaines was appointed as the Chief Customer Officer, responsible for the U.S. commercial organization. These appointments were made by the Board of Directors.
Ticker mentioned:RXST
Source:Original SEC Document â